BioXcel Therapeutics Inc. (BTAI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioXcel Therapeutics Inc.

    NASDAQ: BTAI · Real-Time Price · USD
    2.53
    -0.11 (-4.17%)
    At close: Oct 03, 2025, 3:59 PM
    2.55
    0.77%
    After-hours: Oct 03, 2025, 07:51 PM EDT

    BioXcel Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 29.85M 65.22M 193.72M 232.97M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 87K 87K 925K 3.93M
    Receivables
    		 131K 71K 248K n/a
    Inventory
    		 679K 1.99M 1.99M n/a
    Other Current Assets
    		 1.44M 2.08M 3.84M 956K
    Total Current Assets
    		 37.39M 72.14M 202.87M 236.81M
    Property-Plant & Equipment
    		 857K 1.47M 2.06M 2.54M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 944K 1.56M 2.98M 6.47M
    Total Assets
    		 38.34M 73.7M 205.85M 239.44M
    Account Payables
    		 15.99M 13.65M 10.23M 4.68M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 374K 346K 404K 293K
    Other Current Liabilities
    		 -232K -183K 6.37M 7.43M
    Total Current Liabilities
    		 22.23M 27.27M 32.9M 16.67M
    Long-Term Debt
    		 102.51M 100.6M 93.05M 1.1M
    Other Long-Term Liabilities
    		 6.63M 1.91M 2.34M -1.1M
    Total Long-Term Liabilities
    		 109.21M 102.94M 96.18M 1.1M
    Total Liabilities
    		 131.44M 130.21M 129.08M 17.77M
    Total Debt
    		 102.95M 101.38M 94.16M 1.4M
    Book Value
    		 -93.1M -56.51M 76.78M 221.67M
    Book Value Per Share
    		 -36.73 -31.04 43.85 134.48
    Common Stock
    		 49K 30K 28K 28K
    Retained Earnings
    		 -650.2M -590.6M -411.55M -245.79M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 -93.1M -56.51M 76.78M 221.67M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist